BIOS-0618

N/A

Report date: 2025/08/06 20:01:14
NME

Base Information

Drug NameBIOS-0618
Drug Alias NameBIOS-0618
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistamine H3 receptor antagonists
TargetsHistamine H3 receptor
Therapy Area/IndicationsPainDisorders of Excessive SomnolenceNeuralgia +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesHangzhou Bio-Sincerity Pharma-Tech Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesZhejiang Saimo Pharmaceutical Co LtdHangzhou Bio-Sincerity Pharma-Tech Co Ltd
Inactive CompaniesN/A
Active IndicationsPainDisorders of Excessive SomnolenceNeuralgia +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A